BACKGROUND: The aim of this study was to evaluate the clinical efficacy of humidified oxygen via high-flow nasal cannula (HFNC) alternating with noninvasive ventilation (NIV) in acute hypoxemic respiratory failure (AHRF). METHODS: We performed a prospective observational study in a 12-bed ICU of a university hospital. All subjects with a P aO 2 /F IO2 of ≤ 300 mm Hg with standard mask oxygen and a breathing frequency of > 30 breaths/min or signs of respiratory distress were included and treated with HFNC first and then NIV. Ventilatory parameters, blood gases, and tolerance were recorded during 2 consecutive sessions of NIV and HFNC. Outcome was assessed after continuation of this noninvasive strategy. RESULTS: Twenty-eight subjects with AHRF were studied, including 23 (82%) with ARDS. Compared with standard oxygen therapy, P aO 2 significantly increased from 83 (68–97) mm Hg to 108 (83–140) mm Hg using HFNC and to 125 (97–200) mm Hg using NIV (P
CITATION STYLE
Frat, J. P., Brugiere, B., Ragot, S., Chatellier, D., Veinstein, A., Goudet, V., … Girault, C. (2015). Sequential application of oxygen therapy via high-flow nasal cannula and noninvasive ventilation in acute respiratory failure: An observational pilot study. Respiratory Care, 60(2), 170–178. https://doi.org/10.4187/respcare.03075
Mendeley helps you to discover research relevant for your work.